Kristin S Dabbieri, AGNP-C | |
802 Landmark Dr Ste 120, Glen Burnie, MD 21061-9121 | |
(410) 760-8840 | |
Not Available |
Full Name | Kristin S Dabbieri |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Adult Health |
Location | 802 Landmark Dr Ste 120, Glen Burnie, Maryland |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114652377 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | R192471 (Maryland) | Secondary |
363LA2200X | Nurse Practitioner - Adult Health | R192471 (Maryland) | Primary |
Entity Name | Johns Hopkins Regional Physicians Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1609195320 PECOS PAC ID: 3274720552 Enrollment ID: O20101213000710 |
News Archive
In the wake of the failed attempt by would-be bomber Umar Farouk Abdulmutallab to destroy Northwest flight 253 as it prepared to land in Detroit on Christmas day, airports around the world are considering mandatory installations of full-body (whole body) scanners including backscatter systems. Numerous media organizations have reported on whether radiation exposure from these systems poses a health risk to those who are scanned.
Arena Pharmaceuticals has announced that it was issued U.S. patent number 6,902,902, entitled "Human G Protein-Coupled Receptors and Modulators Thereof for the Treatment of Metabolic-Related Disorders," by the U.S. Patent Office.
About 70 percent of women who have both breasts removed following a breast cancer diagnosis do so despite a very low risk of facing cancer in the healthy breast, new research from the University of Michigan Comprehensive Cancer Center finds
GE Healthcare today announced the receipt of a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use. This opinion recommends the granting of a marketing authorisation for VIZAMYL (Flutemetamol F18 injection), a radiopharmaceutical medicinal product indicated for Positron Emission Tomography imaging of beta amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive impairment.
A new report has found a gaping $250 billion hole in what New York state and local governments have promised to public employees to help pay for their retiree health care costs - a $45 billion increase since 2010.
› Verified 9 days ago
Entity Name | Privia Care Center Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1164874426 PECOS PAC ID: 3274801139 Enrollment ID: O20170619000055 |
News Archive
In the wake of the failed attempt by would-be bomber Umar Farouk Abdulmutallab to destroy Northwest flight 253 as it prepared to land in Detroit on Christmas day, airports around the world are considering mandatory installations of full-body (whole body) scanners including backscatter systems. Numerous media organizations have reported on whether radiation exposure from these systems poses a health risk to those who are scanned.
Arena Pharmaceuticals has announced that it was issued U.S. patent number 6,902,902, entitled "Human G Protein-Coupled Receptors and Modulators Thereof for the Treatment of Metabolic-Related Disorders," by the U.S. Patent Office.
About 70 percent of women who have both breasts removed following a breast cancer diagnosis do so despite a very low risk of facing cancer in the healthy breast, new research from the University of Michigan Comprehensive Cancer Center finds
GE Healthcare today announced the receipt of a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use. This opinion recommends the granting of a marketing authorisation for VIZAMYL (Flutemetamol F18 injection), a radiopharmaceutical medicinal product indicated for Positron Emission Tomography imaging of beta amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive impairment.
A new report has found a gaping $250 billion hole in what New York state and local governments have promised to public employees to help pay for their retiree health care costs - a $45 billion increase since 2010.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Kristin S Dabbieri, AGNP-C 802 Landmark Dr Ste 119, Glen Burnie, MD 21061-9121 Ph: (410) 760-8840 | Kristin S Dabbieri, AGNP-C 802 Landmark Dr Ste 120, Glen Burnie, MD 21061-9121 Ph: (410) 760-8840 |
News Archive
In the wake of the failed attempt by would-be bomber Umar Farouk Abdulmutallab to destroy Northwest flight 253 as it prepared to land in Detroit on Christmas day, airports around the world are considering mandatory installations of full-body (whole body) scanners including backscatter systems. Numerous media organizations have reported on whether radiation exposure from these systems poses a health risk to those who are scanned.
Arena Pharmaceuticals has announced that it was issued U.S. patent number 6,902,902, entitled "Human G Protein-Coupled Receptors and Modulators Thereof for the Treatment of Metabolic-Related Disorders," by the U.S. Patent Office.
About 70 percent of women who have both breasts removed following a breast cancer diagnosis do so despite a very low risk of facing cancer in the healthy breast, new research from the University of Michigan Comprehensive Cancer Center finds
GE Healthcare today announced the receipt of a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use. This opinion recommends the granting of a marketing authorisation for VIZAMYL (Flutemetamol F18 injection), a radiopharmaceutical medicinal product indicated for Positron Emission Tomography imaging of beta amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive impairment.
A new report has found a gaping $250 billion hole in what New York state and local governments have promised to public employees to help pay for their retiree health care costs - a $45 billion increase since 2010.
› Verified 9 days ago